Email:shdiahds@163.com
Phone:+1-909-839-7620
Fax:+1-909-839-7620
Click here for qusetions for this product!
Polyclonal and Monoclonal antibody center
Home
Contact us
Sitemap
Current Country :
Download PDF DatasheetCatalogue No : BS2712
| Host | Reactivity | Size | Application | stock | price | cart |
| BS2712 | H,M,R | 100μg | WB IHC | ![]() |
258.00 | ![]() |
|
Contact information
Email:shdiahds@163.com Click here for qusetions for this product! |
||||||
1 mg/ml in Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.2.
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
CB1 (F189) antibody detects endogenous levels of CB1 protein
WB: 1:500~1:1000 IHC: 1:50~1:200

Immunohistochemistry (IHC) analyzes of CB1 (F189) antibody in paraffin-embedded mouse brain tissue.
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
The cannabinoid receptors (CB1 and CB2) are G protein-coupled receptors that inhibit adenylate cyclase activity in response to psychoactive cannabinoids. CB1 is expressed in brain tissue and, in low levels, in testis. CB2 is expressed only by cells of the immune system. The cannabinoid receptors mediate most of the cannabinoid-induced responses in a dose-dependent, stereoselective manner. This response system is thought to be involved in specific brain functions, such as nociception, control of movement, memory and neuroendocrine regulation, as well as having a possible role in brain development. In addition, CB1 may mediate the addictive behavior involved with the use of psychoactive cannabinoids, such as THC in marijuana.